Burcon NutraScience Statistics
Total Valuation
Burcon NutraScience has a market cap or net worth of 9.43 million. The enterprise value is 13.43 million.
| Market Cap | 9.43M |
| Enterprise Value | 13.43M |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.92% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 92.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 31.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.18 |
| EV / Sales | 69.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.79 |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 4.11.
| Current Ratio | 0.30 |
| Quick Ratio | 0.20 |
| Debt / Equity | 4.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.05 |
| Interest Coverage | -12.20 |
Financial Efficiency
Return on equity (ROE) is -267.87% and return on invested capital (ROIC) is -52.70%.
| Return on Equity (ROE) | -267.87% |
| Return on Assets (ROA) | -48.22% |
| Return on Capital (ROIC) | -52.70% |
| Revenue Per Employee | 8,204 |
| Profits Per Employee | -246,486 |
| Employee Count | 25 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.27% in the last 52 weeks. The beta is 2.85, so Burcon NutraScience's price volatility has been higher than the market average.
| Beta (5Y) | 2.85 |
| 52-Week Price Change | -61.27% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 46.33 |
| Average Volume (20 Days) | 44,596 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Burcon NutraScience had revenue of 205,096 and -6.16 million in losses. Loss per share was -0.05.
| Revenue | 205,096 |
| Gross Profit | -70,447 |
| Operating Income | -5.69M |
| Pretax Income | -6.22M |
| Net Income | -6.16M |
| EBITDA | -5.46M |
| EBIT | -5.69M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 767,602 in cash and 5.03 million in debt, giving a net cash position of -4.26 million.
| Cash & Cash Equivalents | 767,602 |
| Total Debt | 5.03M |
| Net Cash | -4.26M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.23M |
| Book Value Per Share | 0.01 |
| Working Capital | -3.53M |
Cash Flow
In the last 12 months, operating cash flow was -4.60 million and capital expenditures -210,158, giving a free cash flow of -4.81 million.
| Operating Cash Flow | -4.60M |
| Capital Expenditures | -210,158 |
| Free Cash Flow | -4.81M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -34.35% |
| Operating Margin | -2,773.64% |
| Pretax Margin | -3,032.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Burcon NutraScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.92% |
| Shareholder Yield | -16.92% |
| Earnings Yield | -65.37% |
| FCF Yield | -51.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Burcon NutraScience has an Altman Z-Score of -22.56. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.56 |
| Piotroski F-Score | n/a |